Company / Accounts Receivable
uniQure N.V. Accounts Receivable History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$6.6M
FY2020
5-year range
$6.6M / $6.6M
FY2016-FY2020
Trend
-
vs FY2019
Sector context
#97 of 113
Health Care
What the data says
Accounts Receivable changed +317% YoY in FY2020, a notable deviation from the 2-year average annual change of +130%.
Based on SEC 10-K filings.
$7M in FY2020.
Improved from $4M to $7M over the past 4 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +61.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 113This company $6.6M Sector average $1.1B
▼
-99.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +61.0%, indicating consistent growth.
- Ranks #97 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $6.6M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $1.6M | -56.9% |
| FY2016 | $3.7M | - |
| FY2015 | - | - |
As of FY2020 · SEC Form 10-K · Last checked Jul 3, 2026